Drug intelligence / Profile preview

Gufei Tang

Development stage: Unknown
Lead developer: Special subject construction of Guangdong high level University
Administration: Oral

Overview

Gufei Tang is a traditional Chinese medicine formulation, specifically prepared as a granule, currently under investigation for the treatment of combined allergic rhinitis and asthma syndrome. It is being developed by institutions such as the Guangdong Provincial Hospital of Chinese Medicine and the Special subject construction of Guangdong high level University.

Other names: 固肺汤

Beyond the preview

Go deeper on Gufei Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gufei Tang.

Explore the full profile